Merck & Co., Inc. (MRK) Tops Q4 EPS by 2c; Guides In-Line
Tweet
Share
E-mailGet Alerts MRK Hot Sheet
Price: $152.69 +2.48%
Financial Fact:
Income Before Taxes: 10.82B
Today's EPS Names:
BTTX, VAXX, ELYS, More
Financial Fact:
Income Before Taxes: 10.82B
Today's EPS Names:
BTTX, VAXX, ELYS, More
Join SI Premium – FREE
Merck & Co., Inc. (NYSE: MRK) reported Q4 EPS of $0.83, $0.02 better than the analyst estimate of $0.81. Revenue for the quarter came in at $11.7 billion versus the consensus estimate of $11.46 billion.
Merck & Co., Inc. sees FY2013 EPS of $3.60-3.70, versus the consensus of $3.69.
For earnings history and earnings-related data on Merck & Co., Inc. (MRK) click here.
Merck & Co., Inc. sees FY2013 EPS of $3.60-3.70, versus the consensus of $3.69.
For earnings history and earnings-related data on Merck & Co., Inc. (MRK) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Walmart (WMT) PT Lowered to $130 at UBS on Investment Narrative's Competing Dynamics
- Flowers Foods (FLO) Misses Q2 EPS by 3c; Offers Guidance
- Bernstein SocGen on Meta Platforms Inc. (META): 'Risk-reward remains attractive'
Create E-mail Alert Related Categories
Earnings, Guidance, Hot EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
